Navigation Links
Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
Date:5/9/2013

lternatively, Omeros will arrange to send you the prospectus if you request it by calling Omeros at 206-676-5000. 

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-Looking Statements
This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, statements regarding Omeros' expectations regarding the offering announced today and the use of proceeds thereof. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, the risks, uncertainties and other factors described under the heading "Risk Factors" in the Company's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 9, 2013. G
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
2. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
3. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
4. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
5. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
6. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
7. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
8. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
9. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
10. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
11. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Pa. , Dec. 24, 2014  Commonwealth Cornerstone Group ... Markets Tax Credits transaction on Tuesday to help fund the ... Network (PHN) in Sharon . ... in Pennsylvania . It is the largest ... with more than 150 people on staff. Currently, ...
(Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., the ... the proprietary Natural Killer (NK) cell-line platform, Neukoplast® ... Patrick Soon-Shiong , NantWorks founder, physician scientist ... agreement to purchase approximately $48 million of the ... the investment, he will be named Co-Chairman of ...
(Date:12/24/2014)... , Dec. 23, 2014 Echo ... medical device company focused on skin permeation, continuous ... Scott W. Hollander has been appointed ... Hollander has more than 20 years of experience ... industries, and most recently served as Vice President, ...
Breaking Medicine Technology:Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced ... Group in its R&D organization. The new ... the company,s multiple external collaborations already underway or ... phosphatidylserine (PS)-targeting antibody platform for the prevention and ...
... LAKES, N.J., Oct. 7 Medco Health Solutions, Inc. (NYSE: ... find smart solutions for getting the most value out of ... Prescription Plan® has three different plan options - Choice ... in addition to providing access to a vast array of ...
Cached Medicine Technology:Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations 2Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations 3Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations 4Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations 5Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations 6Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 2Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 3Medco's 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 4
(Date:12/25/2014)... December 25, 2014 BambooFlooringChina.com sells many ... quality bamboo flooring. Today, the company announces big ... many styles and colors. , BambooFlooringChina.com is the world’s ... the promotion is valid until Jan. 20, 2015. , ... and woven with a natural thread. All the bamboo ...
(Date:12/25/2014)... December 25, 2014 Recently, LunaDress.co.uk has updated its ... and related accessories. Now, all of the models at LunaDress.co.uk come ... a groom lifts the wedding veil can turn out to be ... charm. A wedding veil can always bring surprise to a wedding. ... on how to choose veils for a big day . ...
(Date:12/25/2014)... 2014 (HealthDay News) -- Overeating is common during the holidays, ... moderation, an expert says. "Don,t arrive at a party ... you know you,ll be attending a party, but deprivation leads ... dietitian at Northern Westchester Hospital in Mount Kisco, N.Y., said ... healthy during the day and even to have a snack ...
(Date:12/25/2014)... 2014 AngelWeddingDress.com tries its best to ... realm. Today, the business has introduced its new collection ... dress promotion. , The new prom outfits are guaranteed ... dress lover. They are specially designed for 2015. Anyone ... dresses should visit its website before Jan. 26, 2015, ...
(Date:12/25/2014)... Viejo, California (PRWEB) December 25, 2014 ... release of ProFire 5k. A fully customizable business presentation ... . , “Adding the ProFire 5k business tool, users ... Said Christina Austin, CEO of Pixel Film Studios. “ProFire ... look and style to add professionalism to a presentation” ...
Breaking Medicine News(10 mins):Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
... by Dr Roger Bayston in the School of Clinical Sciences, ... an allied health professional training fellowship of almost 160,000 from ... bacterial infections associated with broken bones. Pins used ... to 40 per cent of patients being treated in this ...
... NY) The American Association for Cancer Research (AACR), ... awarded Susan Band Horwitz, Ph.D. , the Rose ... molecular pharmacology at Albert Einstein College of Medicine ... Achievement in Cancer Research. Dr. Horwitz, who is ...
... 2011 Those light-emitting diodes marketed as safe, environmentally ... and a dozen other potentially hazardous substances, according to ... next generation of lighting. But as we try to ... or contribute to global warming, we have to be ...
... 10 (HealthDay News) -- People are more likely to recall an ... it is over than if they expect it to occur again, ... as equally enjoyable whether they think they,ll do them again or ... discomfort if they have a bad experience and allow them to ...
... at St. Michael,s Hospital and the Institute for Clinical and ... that will help doctors predict the probability of death in ... in the journal Circulation , found that the tool ... and one year after an ischemic stroke. An ischemic stroke, ...
... living in deprived neighbourhoods are twice as likely to have ... Coast, according to a new study by researchers at St. ... of illness and death are significantly higher in poorer neighbourhoords. ... a big role in how strongly they are affected," said ...
Cached Medicine News:Health News:Anti-bacterial collar to help mend broken bones 2Health News:Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research 2Health News:Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research 3Health News:LED products billed as eco-friendly contain toxic metals, study finds 2Health News:New online tool predicts probability of death from stroke 2Health News:Coastal Canadians living in high-risk neighborhoods in poorer health: Study 2
Patented* Design for Endoscopic Shunt Placement. Designed to pass through standard shunt ventricular catheters for optically guided placement....
Preclude Dura Substitute is the only non-biological membrane designed to "seal" around suture holes. 0.3 mm as nominal thickness....
... Lyoplant is a new ... pericardium. A pure collagen implant, ... to three months, replacing implant ... collagen. Its natural structure minimizes ...
The Bovie IDS Series are the latest electrosurgical generators with fully digital implementation....
Medicine Products: